Skip to main content
OpenTrials

Clinical trial condition

Metal Metabolism, Inborn Errors

Explore clinical trials studying Metal Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

204 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Metal Metabolism, Inborn Errors trial results

Active, Not Recruiting

Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa

NCT06079281

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hypophosphatasia, +4 more
Locations
  • Research Site Indianapolis, Indiana, United States
  • Research Site Garden City, New York, United States
  • Research Site Durham, North Carolina, United States
  • Research Site Columbus, Ohio, United States
View all 65 locations
View Trial Details
Active, Not Recruiting

A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease

NCT04884815

Conditions
Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +16 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Redwood City, California, United States
  • University of California Davis Sacramento, California, United States
  • Northwestern University Chicago, Illinois, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis

NCT04779593

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Haemochromatosis, +7 more
Locations
  • Hopital Avicenne Bobigny, France
  • CHU Dupuytren Limoges, France
  • GHBS site du Scorff Lorient, France
  • GHRMSA - Hôpital Emile Muller Mulhouse, France
View Trial Details
Active, Not Recruiting

Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP

NCT06079359

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hypophosphatasia, +4 more
Locations
  • Research Site Baltimore, Maryland, United States
  • Research Site Kansas City, Missouri, United States
  • Research Site Durham, North Carolina, United States
  • Research Site Nedlands, Australia
View all 32 locations
View Trial Details
Active, Not Recruiting

X-linked Hypophosphatemia Disease Monitoring Program

NCT03651505

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +27 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa

NCT06079372

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hypophosphatasia, +4 more
Locations
  • Research Site Hartford, Connecticut, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Minneapolis, Minnesota, United States
  • Research Site Kansas City, Missouri, United States
View all 21 locations
View Trial Details

Related conditions